Jason Hsu - Sep 11, 2023 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jason Hsu
Stock symbol
IMMX
Transactions as of
Sep 11, 2023
Transactions value $
$200,312
Form type
4
Date filed
9/18/2023, 07:03 PM
Previous filing
Sep 12, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Purchase $72.3K +25K +3.65% $2.89 710K Sep 11, 2023 Direct F1
transaction IMMX Common Stock Purchase $84.9K +30K +4.23% $2.83 740K Sep 12, 2023 Direct F2
transaction IMMX Common Stock Purchase $25.8K +10K +1.35% $2.58 750K Sep 14, 2023 Direct F3
transaction IMMX Common Stock Purchase $17.4K +7K +0.93% $2.49 757K Sep 15, 2023 Direct F4
holding IMMX Common Stock 3.92M Sep 11, 2023 See Footnote F5
holding IMMX Common Stock 50K Sep 11, 2023 See Footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $2.9299 to $2.83, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $2.91 to $2.70, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $2.598 to $2.56, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $2.59 to $2.42, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F5 Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by VERITAS LIBERABIT VOS, LLC, except to the extent of his pecuniary interest therein.
F6 Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by Signature Collection Properties, LLC, except to the extent of his pecuniary interest therein.

Remarks:

See Power of Attorney filed as Exhibit 24.1 to the Form 4 filed by the Reporting Person on December 15, 2021.